Welcome to our dedicated page for Amprius Tech SEC filings (Ticker: AMPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Amprius Technologies, Inc. (NYSE: AMPX), a manufacturer of high-energy and high-power lithium-ion batteries based on a Silicon Anode Platform. These regulatory documents offer detailed insight into the company’s operations, capital structure, executive changes, and financing activities.
Amprius uses current reports on Form 8-K to disclose material events. Recent 8-K filings describe the completion of an at-the-market equity offering program established under an At Market Issuance Sales Agreement, including the aggregate offering size and the resulting net proceeds. Other 8-Ks outline leadership transitions, such as the planned change in Chief Executive Officer, the appointment of a new Chief Financial Officer, and related employment and consulting arrangements, including salary, bonus eligibility, equity awards, and severance terms.
Investors and analysts can also use Amprius’ SEC filings to follow its periodic financial reporting. The company has filed 8-Ks to announce quarterly business and financial results and to furnish letters to shareholders discussing results for specific quarters. These filings complement the company’s earnings press releases and conference calls by providing formal disclosure under SEC rules.
On Stock Titan, AI-powered tools summarize lengthy filings so readers can quickly understand the key points in Amprius’ 10-K annual reports, 10-Q quarterly reports, and 8-K current reports, without needing to parse every technical detail. The platform also surfaces information related to equity compensation, executive employment agreements, and capital-raising activities. Real-time updates from EDGAR ensure that new filings, including any future Forms 4 reporting insider transactions, become available promptly with plain-language explanations to help users interpret their significance.
AMPX68,655 shares of common stock through broker Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of 692,132. The company’s common shares outstanding are listed as 132,344,849 as of the figures in this notice.
The seller acquired 126,193 common shares on 11/20/2025 via a release of restricted stock units from the issuer as compensation. The notice also reports that during the past three months, Kang Sun sold 1,000,000 common shares on 11/17/2025 for gross proceeds of 10,595,300. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about AMPX’s current or prospective operations.
A holder of AMPX25,024 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of
Amprius Technologies, Inc. (AMPX) filed a Form 4 reporting insider transactions by its Chief Executive Officer and director, Kang Sun, on 11/17/2025. Sun exercised multiple stock options for Amprius common stock at exercise prices of $0.98, $0.05, and $0.62 per share and then reported an open market sale of 1,000,000 shares at an average price of $10.5953 per share.
The filing states these option exercises and related sales were carried out under a Rule 10b5-1 trading plan adopted on August 18, 2025. After the reported transactions, Sun beneficially owned 1,472,306 shares directly, which includes 1,411,769 restricted stock units, and an additional 274,275 shares indirectly through a family trust where he and his spouse serve as co-trustees.
A shareholder of AMPX filed a Form 144 notice to sell 1,000,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $11,290,000. The table shows 130,483,838 shares of common stock outstanding. The shares to be sold were acquired on 11/17/2025 by exercising stock options for cash on the same date.
Over the past three months, an individual named Kang Sun sold 65,654 common shares for gross proceeds of $447,510.79. The signer represents that they are not aware of undisclosed material adverse information about AMPX’s current or prospective operations at the time of this planned sale.
Amprius Technologies (AMPX) reported strong top-line growth. Revenue reached
Year‑to‑date, revenue was
Accounts receivable increased to
Amprius Technologies (AMPX) reported that it announced its business and financial results for the third fiscal quarter ended September 30, 2025. The company furnished a Letter to Shareholders as Exhibit 99.1 to a Form 8-K under Item 2.02.
The information in Item 2.02 and Exhibit 99.1 is furnished, not filed, is not subject to Section 18 of the Exchange Act, and is not incorporated by reference unless expressly stated.
The Vanguard Group reported a passive stake in Amprius Technologies (AMPX)6,512,620 shares of common stock, representing 5.20% of the class as of 09/30/2025.
Vanguard has shared voting power over 823,477 shares and no sole voting power. It reports sole dispositive power over 5,579,631 shares and shared dispositive power over 932,989 shares. Vanguard certifies the securities were acquired and are held in the ordinary course and not to change or influence control. The stake is held on behalf of clients, and no single other person’s interest exceeds 5%.
BlackRock, Inc. filed a Schedule 13G reporting beneficial ownership of 7,297,002 shares of Amprius Technologies (AMPX) common stock, representing 5.8% of the class as of September 30, 2025.
BlackRock reports sole voting power over 7,133,356 shares and sole dispositive power over 7,297,002 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course and not for the purpose of changing or influencing control.
Ricardo C. Rodriguez, Chief Financial Officer of Amprius Technologies, Inc. (AMPX), was granted 200,000 restricted stock units on
Amprius Technologies, Inc. (AMPX) filed an initial Form 3 for Ricardo C. Rodriguez, who is reported as the company's Chief Financial Officer. The filing, dated 10/06/2025 for the event and signed 10/08/2025, states that no securities are beneficially owned by the reporting person. The submission includes a Power of Attorney exhibit and a manual signature. This is a routine Section 16 disclosure showing an officer has no reportable equity or derivative positions at the time of filing.